From the 1/14/2022 release of VAERS data:
This is VAERS ID 264373
| Days after submission:||5
|Vaccination / Manufacturer
||Lot / Dose
||Site / Route|
|DTAP: DTAP (NO BRAND NAME) / UNKNOWN MANUFACTURER
||- / UNK
||UN / UN
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.
||- / UNK
||UN / IM
Administered by: Other Purchased by: Other
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Preexisting Conditions: UNK
Diagnostic Lab Data: Body temp between 99 and 103 degrees.
CDC Split Type: WAES0609USA01470
Write-up: Information has been received from a physician concerning a female who on an unspecified date was vaccinated IM with HPV rL1 6 11 16 18 VLP vaccine yeast (0.5ml). Concomitant therapy included Dtap. The day after vaccination with HPV the pt developed a blotchy rash which lasted for three days (site of rash not specified). It was also reported that the pt experienced a fever with a temp between 99 and 103 degrees during the same three day period. Unspecified medical attention was sought. At the time of this report, the pt was recovering from the rash and fever. Additional information has been requested.
Link To This Search Result:
2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166